Advanced Filters
noise
Found 64,776 clinical trials
E Emmanuel Augeraud

Effect of Protein Supplementation on Craving in Subjects Hospitalised for Addiction Treatment

Moncentric pilot study conducted in the addictology department of the Pau Hospital, designed to demonstrate the benefit of protein supplementation on craving in patients with a substance use disorder at the start of their treatment for addiction. This study will be conducted according a crossover design with a one-week phase …

18 years of age All Phase N/A
E Elisavet Moutzouri

Polygenic Risk Score for Optimizing Primary Prevention in Intermediate-Risk Populations

The goal of this clinical trial is to determine whether incorporating a polygenic risk score (PRS) can optimize primary cardiovascular disease prevention in individuals with intermediate cardiovascular risk. The main questions it aims to answer are: Can a polygenic risk score improve risk stratification in intermediate-risk individuals? Does disclosing polygenic …

40 - 69 years of age All Phase N/A

Evaluating the Community Drum Circle

Mental health vulnerability due to stress is increased America due to disproportionate effects of social factors such as racism, poverty, education, and criminal justice sentencing. Various meditation and mindfulness approaches have provided evidence of measured reductions in multiple negative dimensions of stress. However, the majority of these studies do not …

16 - 65 years of age All Phase N/A

Development of a Lifestyle Physical Activity Intervention to Reduce Risk for Perinatal Cannabis Use

This study will recruit 20 women who are high risk for prenatal cannabis use for a 12-week program of using the tracker and receiving a Lifestyle Physical Activity program. The primary outcomes will be self reported percent days of cannabis use and physical activity. Secondary outcomes include self -reported measures …

18 years of age Female Phase N/A
C Chandna Vasandani, Ph.D

Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia

Type I hyperlipoproteinemia (T1HLP, also known as familial chylomicronemia syndrome or FCS) is a rare diseasewhere the blood triglycerides (fats) are very high. It is caused by lack of certain enzymes and proteins in the bodythat are important in disposing circulating fats from blood. Treatment of T1HLP patients who have …

8 years of age All Phase 2

An Exploratory Clinical Study on the Safety and Efficacy of Autologous NK Cells in the Treatment of Pulmonary Nodules

A single-center, open-label dose-escalation design to evaluate the safety and efficacy of KN5001 in patients with pulmonary nodules.

18 - 70 years of age All Phase N/A
X Xzavier Ozuna, MBA

Severe Label Expansion for EVO Products Trial

Title: Severe Label Expansion for EVO Positioner (SLEEP) Study Description: Single-arm study to determine the safety and effectiveness of treating severe obstructive sleep apnea using the EVO Sleep and Snore Device (ProSomnus Sleep Technologies, Pleasanton, CA). Objectives: To determine the safety and effectiveness of the EVO Sleep and Snore Device …

18 - 80 years of age All Phase N/A
K Kangshun Zhu, Dr.

Lenvatinib Plus SIRT vs Lenvatinib in TACE-Refractory HCC

This study is conducted to evaluate the efficacy and safety of lenvatinib plus SIRT (LEN+SIRT) compared with lenvatinib (LEN) alone for patients with hepatocellular carcinoma (HCC) refractory to transarterial chemoembolization (TACE).

18 - 75 years of age All Phase 2
E Emre X Arıkan

Association of Sarcopenia With Rocuronium Use in Liver Transplant Recipients

Patients will be informed by obtaining consent when they meet the inclusion criteria. Written consent will be obtained when the patient arrives in the operating room. The patient's characteristics (gender, age, liver disease) and the biochemistry, hemogram and coagulation values taken before the surgery will be written on the prepared …

18 - 65 years of age All Phase N/A

A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or Obesity

The study is testing the new medicine NNC0662-0419 in people living with overweight or obesity. The purpose of the study is to look into the amount of the new medicine NNC0662-0419 in participants blood after one dose. And also look into how safe and how well the study medicine is …

18 - 55 years of age All Phase 1

Simplify language using AI